Peptide vaccine targeting driver oncogenes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peptide vaccine targeting driver oncogenes, covering 2025-12-05 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) [Phase 1]